Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 4, 2007, Pages 412-416

  Makombe, S D ^a   Harries, A D ^a,b,c   Yu, J K L ^d   Hochgesang, M ^e   Mhango, E ^f   Weigel, R ^f   Pasulani, O ^g,h   Fitzgerald, M ^g,h   Schouten, E J ^a,i   Libamba, E ^a  

^a MINISTRY OF HEALTH   (Malawi)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Mzuzu Central Hospital   (Malawi)

^e US Centres for Disease Control and Prevention   (Malawi)

^f LIGHTHOUSE TRUST   (Malawi)

^g MÉDECINS SANS FRONTIÈRES   (Belgium)

^h Thyolo District Hospital   (Malawi)

ⁱ Ministry of Health ^*  (Malawi)

Author keywords

Antiretroviral therapy; Malawi; Treatment outcomes; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NEVIRAPINE; PYRAZINAMIDE; RIFAMPICIN; STAVUDINE;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; SPUTUM SMEAR; TREATMENT FAILURE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANTI-RETROVIRAL AGENTS; COMORBIDITY; HIV INFECTIONS; HUMANS; MALAWI; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 34247121850     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. World Health Organization and UNAIDS. Progress on Global Access to HIV antiretroviral therapy. A report on '3 by 5' and beyond. Geneva, Switzerland: WHO, 2006.
2. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2006.
3. Dean G L, Edwards S G, Ives N J, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002; 16: 75-83.
4. Hung C-C, Chen M-Y, Hsiao C-F, Hsieh S-M, Sheng W-H, Chang S-C. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 2003; 17: 2615-2622.
5. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand. J Infection 2006; 52: 188-194.
6. Harries A D, Libamba E, Schouten E J, Mwansambo A, Salaniponi F M, Mpazanje R. Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis. BMJ 2004; 329: 1163-1166.
7. Libamba E, Makombe S, Harries A D, et al. Scaling up antiretroviral therapy in Africa: learning from tuberculosis control programmes - the case of Malawi. Int J Tuberc Lung Dis 2005; 9: 1062-1071.
8. National Tuberculosis Control Programme. Manual of the National Tuberculosis Control Programme of Malawi. 5th ed. Lilongwe, Malawi: Ministry of Health and Population, 2002.
9. World Health Organization. Treatment of tuberculosis. Guidelines for national programmes. WHO/CDS/TB.2003.313 Geneva, Switzerland: WHO, 2003.
10. Harries A D, Chimzizi R, Zachariah R. Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings. Lancet 2006; 367: 944-945.
11. Libamba E, Makombe S, Mhango E, et al. Supervision, monitoring and evaluation of nationwide scale up of antiretroviral therapy in Malawi. Bull World Health Organ 2006; 84: 320-326.
12. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: comparison berween low-income and high-income countries. Lancet 2006; 367: 817-824.
13. Kruyt M L, Kruyt N D, Boeree M J, Harries A D, Salaniponi F M L, van Noord P A. True status of smear-positive pulmonary tuberculosis defaulters in Malawi. Bull World Health Organ 1999; 77: 386-391.
14. Zachariah R, Teck R, Ascurra O, et al. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Int J Tuberc Lung Dis 2005; 9: 238-247.
15. Harries A D, Hargreaves N J, Gausi F, Kwanjana J H, Salaniponi F M L. High early mortality in tuberculosis patients in Malawi. Int J Tuberc Lung Dis 2001; 5: 1000-1005.
16. Kangombe C T, Harries A D, Ito K, et al. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis 2004: 8: 829-836.
17. Corbett E L, Marston B, Churchyard G J, De Cock K M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367: 926-937.